|
Volumn 706, Issue 2, 1998, Pages 319-328
|
Quantification of pyrazinamide and its metabolites in plasma by ionic-pair high-performance liquid chromatography. Implications for the separation mechanism
a a a |
Author keywords
5 Hydroxypyrazinamide; 5 Hydroxypyrazinoic acid; Pyrazinamide; Pyrazinoic acid
|
Indexed keywords
5 HYDROXYPYRAZINAMIDE;
5 HYDROXYPYRAZINOIC ACID;
ALLOPURINOL;
DRUG METABOLITE;
ISONIAZID;
OXIPURINOL;
PURINE DERIVATIVE;
PYRAZINAMIDE;
PYRAZINOIC ACID;
TUBERCULOSTATIC AGENT;
UNCLASSIFIED DRUG;
URIC ACID DERIVATIVE;
ARTICLE;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
HUMAN TISSUE;
ION PAIR CHROMATOGRAPHY;
PRIORITY JOURNAL;
QUANTITATIVE ASSAY;
SOLID PHASE EXTRACTION;
TECHNIQUE;
TUBERCULOSIS;
ADMINISTRATION, ORAL;
ANTITUBERCULAR AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CIRCADIAN RHYTHM;
DRUG STABILITY;
HUMANS;
PYRAZINAMIDE;
REPRODUCIBILITY OF RESULTS;
TIME FACTORS;
|
EID: 0032549614
PISSN: 15726495
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(97)00519-7 Document Type: Article |
Times cited : (8)
|
References (21)
|